Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

about

Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies.Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage.

P2860

Q33845573-AE1CBCCB-D045-4F60-8038-088C20B40ABF Q48166311-BB67AE0B-3026-46AA-9D78-AC74AC7537ED

P2860

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

Item

http://www.wikidata.org/entity/Q51293129

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@en

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@nl

type

Item

label

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@en

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@nl

prefLabel

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@en

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@nl

P1476

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

@en

P2093

Azra Hussaini

http://www.w3.org/2001/XMLSchema#string

Clarence Young

http://www.w3.org/2001/XMLSchema#string

Daniel Solorio

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population

Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Recent developments in the treatment of osteoarthritis with NSAIDs.

The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.

Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.

A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine.

P304

1099-1104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-015-3121-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26638161

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

about

P2860

P2860

Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698